We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$312M
AUM Growth
+$403K
Cap. Flow
-$8.88M
Cap. Flow %
-2.85%
Top 10 Hldgs %
68.61%
Holding
42
New
2
Increased
2
Reduced
9
Closed
–

Top Buys

Rank Stock Value
1
CC icon
Chemours
CC
+$3.32M
2
AER icon
AerCap
AER
+$3.32M
3
VG
Venture Global Inc
VG
+$1.46M
4
FATE icon
Fate Therapeutics
FATE
+$245K

Top Sells

Rank Stock Value
1
CMS icon
CMS Energy
CMS
+$4.19M
2
T icon
AT&T
T
+$2.51M
3
DUK icon
Duke Energy
DUK
+$2.28M
4
ABBV icon
AbbVie
ABBV
+$1.94M
5
ABT icon
Abbott
ABT
+$1.85M

Sector Composition

Rank Sector Weight
1 Utilities 26.72%
2 Healthcare 26.16%
3 Industrials 19.04%
4 Financials 9.38%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIRI icon
26
SiriusXM
SIRI
$10.3B
$1.26M 0.4%
55,784
– –
BHC icon
27
Bausch Health
BHC
$1.8B
$1.11M 0.35%
171,000
– –
FOCL
28
EDAP TMS S.A.
FOCL
$204M
$1.09M 0.35%
553,652
– –
VG
29
Venture Global Inc
VG
$34.3B
$1.03M 0.33%
+100,000
New +$1.46M
MNKD icon
30
MannKind Corp
MNKD
$1.25B
$981K 0.31%
195,073
– –
KOD icon
31
Kodiak Sciences
KOD
$2.67B
$908K 0.29%
323,000
– –
ASH icon
32
Ashland
ASH
$3.14B
$889K 0.29%
15,000
– –
PSNL icon
33
Personalis
PSNL
$1.61B
$888K 0.28%
253,000
– –
LVTX
34
DELISTED
LAVA Therapeutics
LVTX
$663K 0.21%
521,874
-250,000
-32% -$278K
VTRS icon
35
Viatris
VTRS
$20.1B
$508K 0.16%
58,279
– –
OGN icon
36
Organon & Co
OGN
$3.55B
$465K 0.15%
31,200
– –
FATE icon
37
Fate Therapeutics
FATE
$324M
$435K 0.14%
550,000
+200,000
+57% +$245K
WEC icon
38
WEC Energy
WEC
$36.9B
$371K 0.12%
3,945
– –
MASS icon
39
908 Devices
MASS
$302M
$306K 0.1%
68,286
– –
CRBU icon
40
Caribou Biosciences
CRBU
$164M
$228K 0.07%
250,000
– –
IGMS
41
DELISTED
IGM Biosciences
IGMS
$115K 0.04%
100,000
– –
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Bruce & Co held 42 positions worth $312M, up 0.13% from $311M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.8%. Bruce & Co opened 2 new positions and made no exits, leaving the 42-position portfolio largely intact.

By sector, the portfolio is most concentrated in Utilities at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Bruce & Co's largest Q1 2025 buy was Chemours: 200,000 shares worth $2.71M.
  • Bruce & Co added most to AerCap in Q1 2025, an estimated $3.32M increase.
  • Bruce & Co's biggest Q1 2025 reduction was CMS Energy, cutting an estimated $4.19M.
  • Bruce & Co's ten largest holdings make up 69% of its $312M portfolio in Q1 2025.
  • Bruce & Co opened 2 new positions and closed 0 in Q1 2025.
  • Bruce & Co's portfolio value rose 0.13% quarter-over-quarter to $312M.

Based on Bruce & Co's 13F filing for Q1 2025, filed 14 May 2025.